|
Unitedhealth Group Common
(UNH)
|
5.9 |
$168M |
+7%
|
330k |
509.97 |
|
Amgen Common
(AMGN)
|
4.9 |
$139M |
|
575k |
241.82 |
|
Regeneron Pharmaceuticals Common
(REGN)
|
3.6 |
$102M |
|
146k |
698.42 |
|
Horizon Therapeutics Shares
(HZNP)
|
3.5 |
$101M |
+5%
|
959k |
105.21 |
|
Gilead Sciences Common
(GILD)
|
3.5 |
$100M |
|
1.7M |
59.45 |
|
Johnson & Johnson Common
(JNJ)
|
3.2 |
$92M |
|
517k |
177.23 |
|
AbbVie Common
(ABBV)
|
3.1 |
$89M |
+4%
|
548k |
162.11 |
|
Vertex Pharmaceuticals Common
(VRTX)
|
2.8 |
$81M |
+13%
|
309k |
260.97 |
|
Illumina Common
(ILMN)
|
2.8 |
$79M |
+16%
|
226k |
349.40 |
|
Abbott Laboratories Common
(ABT)
|
2.6 |
$73M |
-5%
|
619k |
118.36 |
|
AstraZeneca Sponsored ADR
(AZN)
|
2.3 |
$66M |
+21%
|
991k |
66.34 |
|
McKesson Corp. Common
(MCK)
|
2.2 |
$63M |
+13%
|
206k |
306.13 |
|
Pfizer Common
(PFE)
|
2.1 |
$61M |
+160%
|
1.2M |
51.77 |
|
Eli Lilly and Company Common
(LLY)
|
2.1 |
$61M |
-23%
|
212k |
286.37 |
Setup an alert
Hambrecht & Quist Capital Management will file the next quarterly 13-HR in about 3 months. Would you like to be notified?
|
|
Stryker Corp. Common
(SYK)
|
2.1 |
$60M |
+49%
|
226k |
267.35 |
|
Thermo Fisher Scientific Common
(TMO)
|
2.0 |
$58M |
-33%
|
98k |
590.65 |
|
Moderna Common
(MRNA)
|
2.0 |
$57M |
-28%
|
329k |
172.26 |
|
Bristol-Myers Squibb Company Common
(BMY)
|
1.9 |
$53M |
+18%
|
724k |
73.03 |
|
Medtronic Shares
(MDT)
|
1.7 |
$48M |
-27%
|
435k |
110.95 |
|
Seagen Common
(SGEN)
|
1.7 |
$48M |
+59%
|
331k |
144.05 |
|
Merck & Co Common
(MRK)
|
1.7 |
$47M |
-29%
|
576k |
82.05 |
|
Danaher Corp. Common
(DHR)
|
1.5 |
$44M |
|
150k |
293.33 |
|
Cigna Corp. Common
(CI)
|
1.4 |
$41M |
-22%
|
172k |
239.61 |
|
IDEXX Laboratories Common
(IDXX)
|
1.2 |
$34M |
-23%
|
61k |
547.05 |
|
Molina Healthcare Common
(MOH)
|
1.1 |
$32M |
+13%
|
95k |
333.59 |
|
HCA Healthcare Common
(HCA)
|
1.1 |
$31M |
+11%
|
124k |
250.62 |
|
Syneos Health Class A
(SYNH)
|
1.1 |
$31M |
+56%
|
382k |
80.95 |
|
Biogen Common
(BIIB)
|
1.0 |
$29M |
-41%
|
136k |
210.60 |
|
Humana Common
(HUM)
|
1.0 |
$28M |
+19%
|
64k |
435.16 |
|
Zoetis Class A
(ZTS)
|
0.9 |
$27M |
|
141k |
188.59 |
|
Alnylam Pharmaceuticals Common
(ALNY)
|
0.9 |
$26M |
-16%
|
159k |
163.29 |
|
Boston Scientific Corp. Common
(BSX)
|
0.9 |
$25M |
+206%
|
569k |
44.29 |
|
Guardant Health Common
(GH)
|
0.8 |
$23M |
-9%
|
352k |
66.24 |
|
IQVIA Holdings Common
(IQV)
|
0.8 |
$23M |
+28%
|
98k |
231.21 |
|
Jazz Pharmaceuticals Shares
(JAZZ)
|
0.8 |
$22M |
+23%
|
141k |
155.67 |
|
Icon Shares
(ICLR)
|
0.8 |
$22M |
-10%
|
88k |
243.22 |
|
Edwards Lifesciences Corp. Common
(EW)
|
0.7 |
$21M |
-8%
|
177k |
117.72 |
|
Becton, Dickinson and Company Common
(BDX)
|
0.7 |
$20M |
+70%
|
74k |
265.99 |
|
Welltower Common
(WELL)
|
0.7 |
$20M |
|
203k |
96.14 |
|
Dexcom Common
(DXCM)
|
0.7 |
$19M |
-14%
|
37k |
511.60 |
|
Zimmer Biomet Holdings Common
(ZBH)
|
0.6 |
$18M |
-36%
|
142k |
127.90 |
|
Intra-Cellular Therapies Common
(ITCI)
|
0.6 |
$18M |
-10%
|
291k |
61.19 |
|
Sarepta Therapeutics Common
(SRPT)
|
0.6 |
$18M |
-46%
|
228k |
78.12 |
|
Charles River Laboratories International Common
(CRL)
|
0.6 |
$18M |
-21%
|
62k |
283.97 |
|
Intuitive Surgical Common
(ISRG)
|
0.6 |
$17M |
+188%
|
58k |
301.69 |
|
ResMed Common
(RMD)
|
0.6 |
$17M |
+400%
|
71k |
242.51 |
|
Novo Nordisk A/S Sponsored ADR
(NVO)
|
0.6 |
$17M |
+60%
|
154k |
111.05 |
|
BioNTech SE Sponsored ADS
(BNTX)
|
0.6 |
$16M |
+17%
|
95k |
170.56 |
|
Health Care Select Sector SPDR Fund SBI Healthcare
(XLV)
|
0.5 |
$16M |
-14%
|
113k |
136.99 |
|
Ventas Common
(VTR)
|
0.5 |
$15M |
|
248k |
61.76 |
|
Rallybio Corp. Common
(RLYB)
|
0.5 |
$15M |
-4%
|
2.2M |
6.98 |
|
CVS Health Corp. Common
(CVS)
|
0.5 |
$15M |
|
148k |
101.21 |
|
United Therapeutics Corp. Common
(UTHR)
|
0.5 |
$13M |
-50%
|
72k |
179.40 |
|
Karuna Therapeutics Common
(KRTX)
|
0.4 |
$13M |
|
101k |
126.79 |
|
Owens & Minor Common
(OMI)
|
0.4 |
$13M |
-2%
|
288k |
44.02 |
|
argenx SE Sponsored ADR
(ARGX)
|
0.4 |
$12M |
|
39k |
315.32 |
|
Novartis Sponsored ADR
(NVS)
|
0.4 |
$12M |
|
136k |
87.75 |
|
Neurocrine Biosciences Common
(NBIX)
|
0.4 |
$12M |
|
125k |
93.75 |
|
Laboratory Corporation of America Holdings Sponsored ADR
(LH)
|
0.4 |
$12M |
-53%
|
44k |
263.65 |
|
Ultragenyx Pharmaceutical Common
(RARE)
|
0.4 |
$10M |
|
141k |
72.62 |
|
Apellis Pharmaceuticals Common
(APLS)
|
0.3 |
$10M |
|
196k |
50.81 |
|
BioMarin Pharmaceutical Common
(BMRN)
|
0.3 |
$9.9M |
|
128k |
77.10 |
|
BeiGene Sponsored ADR
(BGNE)
|
0.3 |
$9.6M |
-19%
|
51k |
188.60 |
|
Omega Healthcare Investors Common
(OHI)
|
0.3 |
$9.5M |
|
306k |
31.16 |
|
uniQure Shares
(QURE)
|
0.3 |
$9.4M |
+120%
|
522k |
18.07 |
|
Agilent Technologies Common
(A)
|
0.3 |
$8.8M |
+68%
|
67k |
132.34 |
|
Waters Corp. Common
(WAT)
|
0.3 |
$8.8M |
|
29k |
310.39 |
|
Medical Properties Trust Common
(MPW)
|
0.3 |
$8.7M |
|
412k |
21.14 |
|
Physicians Realty Trust Common
(DOC)
|
0.3 |
$8.7M |
|
496k |
17.54 |
|
SPDR S&P Biotech ETF S&P Biotech ETF
(XBI)
|
0.3 |
$8.6M |
NEW
|
96k |
89.88 |
|
Biohaven Pharmaceutical Holding Company Common
(BHVN)
|
0.3 |
$8.3M |
-22%
|
70k |
118.57 |
|
Align Technology Common
(ALGN)
|
0.3 |
$8.2M |
+153%
|
19k |
436.01 |
|
Ascendis Pharma A/S Sponsored ADR
(ASND)
|
0.3 |
$8.0M |
|
68k |
117.36 |
|
Addus HomeCare Corp. Common
(ADUS)
|
0.3 |
$7.8M |
|
84k |
93.29 |
|
Sabra Health Care REIT Common
(SBRA)
|
0.3 |
$7.6M |
|
511k |
14.89 |
|
Anthem Common
(ANTM)
|
0.3 |
$7.2M |
|
15k |
491.19 |
|
Denali Therapeutics Common
(DNLI)
|
0.3 |
$7.2M |
|
222k |
32.17 |
|
LTC Properties Common
(LTC)
|
0.2 |
$7.0M |
|
182k |
38.47 |
|
HealthEquity Common
(HQY)
|
0.2 |
$7.0M |
NEW
|
103k |
67.44 |
|
Mirati Therapeutics Common
(MRTX)
|
0.2 |
$6.9M |
|
84k |
82.22 |
|
Ionis Pharmaceuticals Common
(IONS)
|
0.2 |
$6.5M |
-45%
|
176k |
37.04 |
|
Caribou Biosciences Common
(CRBU)
|
0.2 |
$6.4M |
|
699k |
9.18 |
|
AMN Healthcare Services Common
(AMN)
|
0.2 |
$6.4M |
NEW
|
61k |
104.33 |
|
Travere Therapeutics Common
(TVTX)
|
0.2 |
$6.4M |
+16%
|
248k |
25.77 |
|
Sanofi Sponsored ADR
(SNY)
|
0.2 |
$6.3M |
-19%
|
124k |
51.34 |
|
Blueprint Medicines Corp. Common
(BPMC)
|
0.2 |
$6.2M |
NEW
|
97k |
63.88 |
|
Arrowhead Pharmaceuticals Common
(ARWR)
|
0.2 |
$6.2M |
-33%
|
135k |
45.99 |
|
PerkinElmer Common
(PKI)
|
0.2 |
$5.8M |
|
33k |
174.47 |
|
Smith & Nephew Sponsored ADR
(SNN)
|
0.2 |
$5.8M |
|
182k |
31.90 |
|
Arvinas Common
(ARVN)
|
0.2 |
$5.8M |
|
86k |
67.30 |
|
R1 RCM Common
(RCM)
|
0.2 |
$5.4M |
|
202k |
26.76 |
|
Qiagen Shares
(QGEN)
|
0.2 |
$5.3M |
|
108k |
49.00 |
|
Healthpeak Properties Common
(PEAK)
|
0.2 |
$5.2M |
|
150k |
34.33 |
|
Koninklijke Philips NY Reg Shares
(PHG)
|
0.2 |
$5.0M |
|
165k |
30.53 |
|
Alkermes Shares
(ALKS)
|
0.2 |
$5.0M |
-49%
|
190k |
26.31 |
|
Acadia Healthcare Company Common
(ACHC)
|
0.2 |
$4.7M |
NEW
|
72k |
65.53 |
|
Novavax Common
(NVAX)
|
0.2 |
$4.7M |
-57%
|
64k |
73.65 |
|
Adaptive Biotechnologies Corp. Common
(ADPT)
|
0.2 |
$4.7M |
|
338k |
13.88 |
|
Cytokinetics Common
(CYTK)
|
0.2 |
$4.4M |
NEW
|
120k |
36.81 |
|
Teva Pharmaceutical Industries Sponsored ADR
(TEVA)
|
0.2 |
$4.3M |
-24%
|
460k |
9.39 |
|
Intellia Therapeutics Common
(NTLA)
|
0.1 |
$4.2M |
|
58k |
72.67 |
|
Steris Shares
(STE)
|
0.1 |
$4.0M |
|
17k |
241.77 |
|
Verona Pharma Sponsored ADR
(VRNA)
|
0.1 |
$3.8M |
|
752k |
4.99 |
|
VectivBio Holding Ordinary Shares
(VECT)
|
0.1 |
$3.6M |
|
757k |
4.70 |
|
CRISPR Therapeutics Namen AKT
(CRSP)
|
0.1 |
$3.5M |
-66%
|
55k |
62.76 |
|
G1 Therapeutics Common
(GTHX)
|
0.1 |
$3.2M |
-32%
|
424k |
7.60 |
|
BioCryst Pharmaceuticals Common
(BCRX)
|
0.1 |
$3.2M |
NEW
|
197k |
16.26 |
|
Takeda Pharmaceutical Company Sponsored ADS
(TAK)
|
0.1 |
$3.0M |
|
210k |
14.32 |
|
Xencor Common
(XNCR)
|
0.1 |
$3.0M |
NEW
|
113k |
26.68 |
|
Protagonist Therapeutics Common
(PTGX)
|
0.1 |
$2.9M |
+41%
|
122k |
23.68 |
|
Healthcare Realty Trust Common
(HR)
|
0.1 |
$2.9M |
|
104k |
27.48 |
|
Global Medical REIT Common
(GMRE)
|
0.1 |
$2.9M |
|
175k |
16.32 |
|
Dentsply Sirona Common
(XRAY)
|
0.1 |
$2.8M |
-84%
|
57k |
49.22 |
|
Helix Acquisition Corp. Class A
|
0.1 |
$2.8M |
|
250k |
11.10 |
|
I-Mab Sponsored ADS
(IMAB)
|
0.1 |
$2.6M |
|
163k |
16.24 |
|
Pyxis Oncology Common
(PYXS)
|
0.1 |
$2.6M |
NEW
|
708k |
3.71 |
|
Cerevel Therapeutics Holdings Common
(CERE)
|
0.1 |
$2.6M |
NEW
|
74k |
35.02 |
|
Affimed Common
(AFMD)
|
0.1 |
$2.6M |
|
586k |
4.37 |
|
Arcutis Biotherapeutics Common
(ARQT)
|
0.1 |
$2.5M |
|
132k |
19.26 |
|
Merus Common
(MRUS)
|
0.1 |
$2.5M |
NEW
|
95k |
26.44 |
|
Healthcare Trust of America Common
(HTA)
|
0.1 |
$2.2M |
|
71k |
31.35 |
|
Hologic Common
(HOLX)
|
0.1 |
$2.2M |
|
28k |
76.83 |
|
Galera Therapeutics Common
(GRTX)
|
0.1 |
$2.1M |
|
898k |
2.38 |
|
Aurinia Pharmaceuticals Common
(AUPH)
|
0.1 |
$2.0M |
-35%
|
163k |
12.38 |
|
Perrigo Company Shares
(PRGO)
|
0.1 |
$2.0M |
|
51k |
38.44 |
|
ChemoCentryx Common
(CCXI)
|
0.1 |
$2.0M |
|
78k |
25.06 |
|
Zai Lab Adr
(ZLAB)
|
0.1 |
$1.9M |
+15%
|
43k |
43.97 |
|
Fulcrum Therapeutics Common
(FULC)
|
0.1 |
$1.8M |
+76%
|
77k |
23.65 |
|
ACADIA Pharmaceuticals Common
(ACAD)
|
0.1 |
$1.7M |
NEW
|
72k |
24.22 |
|
Mereo BioPharma Group Ads
(MREO)
|
0.1 |
$1.7M |
|
1.6M |
1.12 |
|
Medpace Holdings Common
(MEDP)
|
0.1 |
$1.5M |
-50%
|
9.4k |
163.54 |
|
Stevanato Group Societa' Per Azioni Ordinary Shares
(STVN)
|
0.1 |
$1.4M |
-48%
|
71k |
20.12 |
|
Morphic Holding Common
(MORF)
|
0.0 |
$1.4M |
|
35k |
40.14 |
|
Scholar Rock Holding Corp. Common
(SRRK)
|
0.0 |
$1.4M |
|
109k |
12.89 |
|
iTeos Therapeutics Common
(ITOS)
|
0.0 |
$1.4M |
|
42k |
32.18 |
|
Sutro Biopharma Common
(STRO)
|
0.0 |
$1.3M |
-59%
|
164k |
8.22 |
|
Harpoon Therapeutics Common
(HARP)
|
0.0 |
$1.3M |
NEW
|
260k |
4.97 |
|
Adicet Bio Common
(ACET)
|
0.0 |
$1.3M |
NEW
|
63k |
19.98 |
|
Fate Therapeutics Common
(FATE)
|
0.0 |
$1.2M |
-56%
|
32k |
38.77 |
|
Assertio Holdings Common
(ASRT)
|
0.0 |
$1.2M |
|
411k |
2.87 |
|
Theseus Pharmaceuticals Common
(THRX)
|
0.0 |
$1.2M |
NEW
|
100k |
11.53 |
|
Diversified Healthcare Trust Common
(DHC)
|
0.0 |
$1.1M |
|
358k |
3.20 |
|
Endo International Shares
(ENDP)
|
0.0 |
$1.1M |
|
495k |
2.31 |
|
ALX Oncology Holdings Common
(ALXO)
|
0.0 |
$1.1M |
+832%
|
66k |
16.90 |
|
Design Therapeutics Common
(DSGN)
|
0.0 |
$1.1M |
NEW
|
65k |
16.14 |
|
Community Health Systems Common
(CYH)
|
0.0 |
$1.0M |
-13%
|
88k |
11.88 |
|
Syndax Pharmaceuticals Common
(SNDX)
|
0.0 |
$982k |
NEW
|
57k |
17.39 |
|
Beam Therapeutics Common
(BEAM)
|
0.0 |
$906k |
NEW
|
16k |
57.28 |
|
Intercept Pharmaceuticals Common
(ICPT)
|
0.0 |
$847k |
|
52k |
16.27 |
|
Prometheus Biosciences Common
(RXDX)
|
0.0 |
$835k |
NEW
|
22k |
37.76 |
|
Praxis Precision Medicines Common
(PRAX)
|
0.0 |
$766k |
|
75k |
10.21 |
|
Precision BioSciences Common
(DTIL)
|
0.0 |
$692k |
+256%
|
225k |
3.08 |
|
Universal Health Realty Income Trust Shares
(UHT)
|
0.0 |
$657k |
|
11k |
58.36 |
|
Community Healthcare Trust Common
(CHCT)
|
0.0 |
$629k |
|
15k |
42.21 |
|
National Health Investors Common
(NHI)
|
0.0 |
$592k |
|
10k |
58.98 |
|
Edgewise Therapeutics Common
(EWTX)
|
0.0 |
$587k |
NEW
|
61k |
9.69 |
|
Universal Health Services Class B
(UHS)
|
0.0 |
$580k |
-93%
|
4.0k |
145.00 |
|
Ardelyx Common
(ARDX)
|
0.0 |
$577k |
|
539k |
1.07 |
|
TScan Therapeutics Common
(TCRX)
|
0.0 |
$560k |
|
200k |
2.80 |
|
MorphoSys Sponsored ADS
(MOR)
|
0.0 |
$555k |
|
82k |
6.78 |
|
Avidity Biosciences Common
(RNA)
|
0.0 |
$489k |
NEW
|
27k |
18.49 |
|
Bicycle Therapeutics Sponsored ADS
(BCYC)
|
0.0 |
$443k |
NEW
|
10k |
43.92 |
|
Repare Therapeutics Common
(RPTX)
|
0.0 |
$415k |
NEW
|
29k |
14.24 |
|
Black Diamond Therapeutics Common
(BDTX)
|
0.0 |
$366k |
|
132k |
2.77 |
|
1Life Healthcare Common
(ONEM)
|
0.0 |
$346k |
|
31k |
11.07 |
|
Fusion Pharmaceuticals Common
(FUSN)
|
0.0 |
$337k |
|
43k |
7.77 |
|
Nkarta Common
(NKTX)
|
0.0 |
$330k |
|
29k |
11.38 |
|
ZimVie Common
|
0.0 |
$324k |
NEW
|
14k |
22.81 |
|
Spectrum Pharmaceuticals Common
(SPPI)
|
0.0 |
$148k |
|
115k |
1.29 |
|
VYNE Therapeutics Common
(VYNE)
|
0.0 |
$88k |
|
135k |
0.65 |
|
Corbus Pharmaceuticals Holdings Common
(CRBP)
|
0.0 |
$82k |
-62%
|
154k |
0.53 |
|
ARCA biopharma Common
(ABIO)
|
0.0 |
$75k |
|
33k |
2.31 |
|
AlerisLife Common
(ALR)
|
0.0 |
$52k |
|
24k |
2.15 |
|
Bellicum Pharmaceuticals Common
(BLCM)
|
0.0 |
$13k |
|
6.0k |
2.17 |
|
NexGel Common
(NXGL)
|
0.0 |
$8.0k |
NEW
|
4.2k |
1.89 |